| scholarly article | Q13442814 |
| P356 | DOI | 10.3810/PGM.1997.06.224 |
| P8608 | Fatcat ID | release_kwpoqq3ikvgalod2vdff56igoi |
| P698 | PubMed publication ID | 9194867 |
| P2093 | author name string | L Schneider | |
| P N Tariot | |||
| A P Porsteinsson | |||
| P2860 | cites work | Potential use of nerve growth factor to treat Alzheimer's disease | Q38635096 |
| Inflammatory mechanisms in Alzheimer's disease: implications for therapy | Q40390940 | ||
| Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group | Q40935673 | ||
| Anticonvulsant and other non-neuroleptic treatment of agitation in dementia | Q40945369 | ||
| Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study | Q42633058 | ||
| A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group | Q44110810 | ||
| Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. | Q52259713 | ||
| The effect of long-term physostigmine administration in Alzheimer's disease. | Q52473132 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 73-6, 81, 84 passim | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Postgraduate Medicine | Q7234297 |
| P1476 | title | Treating Alzheimer's disease. Pharmacologic options now and in the near future | |
| P478 | volume | 101 |
Search more.